Nutex Health Inc
Statements
Income Statement
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 11 | Q4 11 | Q1 16 | Q2 16 | Q3 16 | Q1 17 | Q2 17 | Q3 17 | Q1 18 | Q2 18 | Q3 18 | Q1 19 | Q2 19 | Q3 19 | Q1 20 | Q2 20 | Q3 20 | Q4 20 | Q1 21 | Q2 21 | Q3 21 | Q4 21 | Q1 22 | Q2 22 | Q3 22 | Q4 22 | Q1 23 | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 63.5% | 62.8% | 2.3% | 5.4% | 1.5% | 302.0% | 7,404.4% | 59.0% | 4,339.1% | 4,892.5% | 807.0% | 79.4% | 84.1% | 42.8% | 71.6% | 93.1% | 60.2% | – | 78.8% | 53.6% | 35.6% | 64.9% | 54.7% | 88.6% | 183.5% | 99.0% | 91.4% | 83.6% | 81.2% | 81.0% | 84.9% | 70.3% | 72.2% | 45.0% | 44.1% | 48.8% | 42.2% | 69.6% | 57.6% | 33.0% | 48.7% | |
| 36.5% | 37.2% | 97.7% | 94.6% | 98.5% | -202.0% | -7,304.4% | 41.0% | -4,239.1% | -4,792.5% | -707.0% | 20.6% | 15.9% | 57.2% | 28.4% | 6.9% | 39.8% | – | 21.2% | 46.4% | 64.4% | 35.1% | 45.3% | 11.4% | -83.5% | 1.0% | 8.6% | 16.4% | 18.8% | 19.0% | 15.1% | 29.7% | 27.8% | 55.0% | 55.9% | 51.2% | 57.8% | 30.4% | 42.4% | 67.0% | 51.3% | |
| – | – | – | – | – | – | – | – | – | – | – | 85.4% | 63.4% | – | 24.7% | 83.0% | 21.1% | – | 3.8% | 0.1% | 0.1% | 0.3% | 0.1% | – | – | 0.1% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| 76.3% | 71.1% | – | – | – | – | 26,957.6% | 2,681.4% | 5,588.4% | 8,343.3% | 920.2% | 89.7% | 44.7% | 96.2% | 663.8% | 354.4% | 199.6% | 38.7% | 219.7% | 2.4% | 1.3% | 0.6% | 8.3% | 7.1% | 24.1% | 11.7% | 16.1% | 17.0% | 12.5% | 13.1% | 12.9% | 13.9% | 15.0% | 10.6% | 4.7% | 37.4% | 4.2% | 11.8% | 6.6% | 9.3% | 7.4% | |
| 76.3% | 71.1% | 136.8% | 97.4% | 56.9% | 3,549.9% | 19,867.3% | 2,681.4% | 5,588.4% | 8,331.7% | 918.3% | 457.1% | 349.6% | 185.6% | 230.2% | 451.3% | 219.2% | 40.3% | 227.2% | 2.4% | 1.3% | 10.6% | 8.3% | 13.8% | 1,426.2% | -7.5% | 16.5% | 17.0% | 20.1% | 56.5% | 12.9% | 22.7% | 15.6% | 10.6% | 21.8% | 86.2% | 9.2% | 10.0% | 4.8% | 9.3% | 8.2% | |
| -39.8% | -33.9% | -39.2% | -2.8% | 41.5% | -3,752.0% | -27,171.7% | 9,457.0% | -57,068.1% | -66,273.1% | -10,394.7% | -39,401.5% | -18,772.9% | -42,948.3% | -201.9% | -444.4% | -179.4% | 59.7% | -206.0% | 43.9% | 63.1% | 24.5% | 37.0% | -2.4% | -1,509.7% | 8.5% | -7.9% | -0.6% | -1.3% | -37.5% | 2.1% | 7.0% | 12.3% | 44.3% | 34.1% | 13.8% | 48.7% | 20.4% | 37.5% | 57.8% | 43.0% | |
| – | – | 20.9% | 13.5% | 14.5% | 72.5% | 37.8% | 61.8% | 388.0% | 2,055.2% | 983.7% | 19.9% | 3.3% | 5.1% | 14.0% | 65.8% | 5.2% | 1.6% | 16.6% | 2.4% | 1.1% | 3.1% | 2.3% | 7.5% | 12.0% | 5.3% | 5.6% | 8.2% | 6.5% | 6.1% | 6.6% | 6.6% | 6.8% | 2.0% | 2.9% | 2.3% | 2.0% | 3.3% | 2.2% | 2.2% | 2.3% | |
| -38.5% | -33.0% | -60.0% | -16.2% | 27.1% | -4,026.1% | -35,848.7% | -1,189.2% | -103,489.1% | -119,551.2% | -19,204.5% | -37,226.8% | -17,737.7% | -40,484.2% | -215.8% | 60.0% | 501.7% | 57.1% | -222.6% | 48.0% | 63.5% | 21.1% | 31.6% | -7.5% | -1,519.5% | 2.8% | -13.9% | -8.6% | -7.8% | -44.1% | -0.2% | 5.1% | -3.3% | 42.1% | 29.6% | 9.7% | 46.3% | 17.1% | 35.4% | 55.6% | 40.6% | |
| -12.9% | -11.3% | – | – | – | – | – | – | 1,855.7% | – | – | -19.0% | -9.2% | -22.9% | -10.0% | -13.5% | -15.1% | – | -2.0% | 0.8% | 0.4% | -0.2% | 0.2% | 33.9% | -30.1% | 3.4% | -1.6% | -1.4% | -0.5% | -4.3% | 0.6% | 1.2% | 5.8% | 3.3% | 8.8% | – | 10.1% | 6.1% | 6.4% | 9.9% | 8.4% | |
| -25.5% | -21.7% | -59.2% | -16.3% | 27.2% | -5,564.9% | -35,848.7% | 23,457.3% | -14,552.3% | -19,491.3% | -2,694.7% | -456.4% | -366.2% | -440.7% | -271.6% | 60.0% | 501.7% | 37.9% | -220.6% | 43.1% | 45.6% | 22.0% | 27.1% | -33.2% | -1,451.6% | -8.2% | -9.1% | -5.9% | -8.8% | -45.4% | -0.5% | -0.5% | -11.2% | 23.9% | 6.9% | -7.3% | 20.7% | 7.8% | 21.6% | 31.2% | 21.2% | |
| -39.8% | 0.7% | -37.6% | -1.7% | 42.1% | -3,655.7% | -28,720.6% | -2,640.3% | -14,154.0% | -8,443.6% | 2,700.7% | -200.8% | -323.0% | -465.1% | -171.9% | 150.1% | 508.2% | 40.2% | -202.8% | 56.7% | 66.2% | 32.2% | 37.0% | 5.4% | -1,492.2% | 14.2% | -1.2% | 6.7% | 1.8% | -31.3% | 12.6% | 17.7% | 9.9% | 46.2% | 34.9% | 14.2% | 50.2% | 23.8% | 40.1% | 60.3% | 45.4% |
LTM = last twelve months (sum of the four most recent quarters).
Showing the most recent 40 periods — older statements are on file for this stock.
Data as of: October 9, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.